Cardiovascular Risk Reduction in Patients with Type 2 Diabetes
Webcast CME Disclosure
Please read this notice and click the acknowledgement
Method of Physician Participation Utilized in Learning Process
There are no fees for participating and receiving CME credit for this activity. During the period July 17, 2012 through July 17, 2014 participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity, and are expected to view all five segments totaling 2 hours and 10 minutes to successfully complete the activity and earn CME credit; 3) register and complete the evaluation form and post-test; 4) score 100% on the post-test; and 5) print out your CME certificate.
Estimated Time to Complete Educational Activity
In this web-based program, physicians will learn how recent advances in basic and clinical research have helped to advance the understanding of treatment advances in type 2 diabetes.
July 17, 2012
July 17, 2014
This program is intended for all primary care, internal medicine, and endocrinology specialists, as well as other healthcare providers caring for patients with diabetes.
Enrollment for this WebCAST is complimentary, and clinicians are invited to participate in this CME-certified WebCAST and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.
This CME activity is supported by an
Physician Continuing Education
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The University of Massachusetts Medical School, Office of CME and CMEducation Resources, LLC. The University of Massachusetts Medical School is accredited by the ACCME to provide continuing medical education for physicians.
The University of Massachusetts Medical School designates this enduring material for a maximum of 2.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest
It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity, and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials
Program Faculty and Disclosure
A. MICHAEL LINCOFF, MD
Consultant: AstraZeneca, Avanir, Baxter, Bristol-Myers Squibb, Ikaria, Roche, Merck/Schering-Plough
JORGE PLUTZKY, MD
Consultant: Abbott Laboratories; Amylin Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; ChemoCentryz Inc.; Daiichi Sankyo, Inc.; Genentech, Inc.; GlaxoSmithKline; Novo Nordisk; Orexigen Therapeutics, Inc.; Roche; Takeda Pharmaceuticals North America, Inc.; Theratechnologies, Inc.
Program Managers and Web Editor Disclosure
Program Manager Gideon Bosker, MD has nothing to disclose.
Upon completion of this educational activity, participants should:
Hardware and Software Requirements:
To participate in this program, viewers must have a PC or Macintosh computer that has active, ongoing internet access for the duration of the program, as well as a compatible Flash-viewer. An email address is required for registration, and a printer is required to printout the CME certificate.
When you participate in a CME activity offered by CMEducation Resources, we ask you for your name, degree, affiliation, street address, telephone number, fax number, and/or e-mail address (the "Information"). We use that Information in the following ways:
Copyright © 2012 by Pharmatecture, LLC and CMEducation Resources, LLC All rights reserved.
Reproduction, distribution, or translation without express written permission is strictly prohibited.
Content on this webcast reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.
Content on this webcast is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.
Content on this webcast is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This webcast is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This webcast is not intended for use by the layman.
Opinions expressed herein are not necessarily those of Pharmatecture, LLC, CMEducation Resources, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations.
Copyright © CMEducation Resources, LLC and Pharmatecture, LLC